Tyrosine kinase inhibition attenuates vasopressin-induced contraction of mesenteric resistance arteries: Alterations in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 1, 2002, Pages 123-132

  Endemann, Dierk ^a   Touyz, Rhian M ^a   Yao, Guoying ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Protein tyrosine kinases; Tyrphostins; Vascular smooth muscle; Vasoactive peptides

Indexed keywords

ARGIPRESSIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; ENZYME INHIBITOR; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HYPERTENSION; INTESTINE PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; VASCULAR RESISTANCE; VASOCONSTRICTION; WISTAR KYOTO RAT;

ANIMAL; CELLS, CULTURED; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; IN VITRO; MALE; MESENTERIC ARTERIES; PROTEIN-TYROSINE KINASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUPPORT, NON-U.S. GOV'T; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOPRESSINS; ANIMALS; PROTEIN-TYROSINE KINASES;

EID: 0035985566     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200207000-00015     Document Type: Article

References (38)

1. Regulation of contraction and relaxation in arterial smooth muscle
2. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
3. Inositol trisphosphate and calcium signaling
4. Integration of transmembrane signaling. Cross talk among G-protein-linked receptors and other signal transduction pathways
5. Tyrosine kinase dependent signaling pathways
6. Vasoconstrictor induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells
7. Endothelin, vasopressin and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells
8. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells
9. Calcium signaling
10. Signal transduction by G proteins, Rho kinase and protein phosphatase to smooth muscle and non myosin II
11. 2+ sensitization by PKC and Rho proteins in ovine cerebral arteries: Effects of artery size and age
12. 2+ sensitivity for contraction of smooth muscle
13. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries
14. Tyrosine kinase pathways and the regulation of smooth muscle contractility
15. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle
16. Tyrosine kinase inhibition suppresses Ang II contraction in hypertensive and normotensive small resistance arteries
17. Vasopressin and blood pressure regulation
18. Vasopressin receptors and inositol trisphosphate production in blood vessels of SHR
19. Endothelin-1 and vasopressin signaling in blood vessels of young SHR in comparison to adult SHR
20. Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats
21. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured vascular smooth muscle cells
22. Vasopressin stimulates tyrosine phosphorylation by activation of PKC in the rat smooth muscle cell line, A-10
23. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin II receptor antagonist losartan
24. Cellular and molecular mechanisms regulating vascular function and structure: Implications in the pathogenesis of hypertension
25. Tyrphostins as molecular tools and potential antiproliferative drugs
26. Tyrosine kinase inhibition: An approach to drug development
27. Altered angiotensin II-stimulated small artery contraction in the development of hypertension in SHR
28. Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells
29. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates Ang II-mediated signaling and contraction in SHR vascular smooth muscle cells
30. i) transients in vascular smooth muscle cells
31. Involvement of tyrsine phosphorylation in endothelin-1 induced calcium-sensitization in rat small mesenteric arteries
32. 2+ signaling by angiotensin II in human vascular smooth muscle cells
33. Tyrosine kianses modulate the activity of single L-type Ca2+ channels in vascular smooth muscle cells from rat portal vein
34. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells
35. 2+ signaling in rat vascular smooth muscle cells: A role for PKC at physiological vasoconstrictor concentrations of vasopressin
36. Bombesin, vasopressin, lysophosphatidic acid, and sphingosylphosphorylcholine induce focal adhesion kinase activation in intact Swiss 3T3 cells
37. Differential Ang II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR
38. Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II